← Back to headlines
Repligen to Acquire BioLife Solutions in $1.5 Billion Deal
Repligen announced its intention to acquire BioLife Solutions in a $1.5 billion stock-and-cash deal. This acquisition aims to expand Repligen's cell therapy business.
22 Jul, 10:06 — 22 Jul, 12:04
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (27/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left1
Left (1)
Yahoo
Center
Right1
Right (1)
seeking-alpha
Far R
Geographic diversity— 1 region4/34
US2
ℹAll sources from US region
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
Coverage Timeline
First report: seeking-alpha · 22 Jul, 10:06|Full coverage: 2 · 2h|Window: 2h
Left-leaningCenterRight-leaning
